Year |
Citation |
Score |
2019 |
Pfau JC, McNew T, Hanley K, Swan L, Black B. Autoimmune markers for progression of Libby amphibole lamellar pleural thickening. Inhalation Toxicology. 1-11. PMID 31814459 DOI: 10.1080/08958378.2019.1699616 |
0.37 |
|
2019 |
Christofidou-Solomidou M, Pietrofesa RA, Park K, Albelda SM, Serve KM, Keil DE, Pfau JC. Synthetic secoisolariciresinol diglucoside (LGM2605) inhibits Libby amphibole fiber-induced acute inflammation in mice. Toxicology and Applied Pharmacology. PMID 31022494 DOI: 10.1016/J.Taap.2019.04.018 |
0.715 |
|
2018 |
Pfau JC, Barbour C, Black B, Serve KM, Fritzler MJ. Analysis of autoantibody profiles in two asbestiform fiber exposure cohorts. Journal of Toxicology and Environmental Health. Part A. 1-13. PMID 30230971 DOI: 10.1080/15287394.2018.1512432 |
0.73 |
|
2018 |
Diegel R, Black B, Pfau JC, McNew T, Noonan C, Flores R. Case series: rheumatological manifestations attributed to exposure to Libby Asbestiform Amphiboles. Journal of Toxicology and Environmental Health. Part A. 1-14. PMID 29927712 DOI: 10.1080/15287394.2018.1485124 |
0.48 |
|
2018 |
Reid A, Franklin P, de Klerk N, Creaney J, Brims F, Musk B, Pfau J. Autoimmune antibodies and asbestos exposure: Evidence from Wittenoom, Western Australia. American Journal of Industrial Medicine. PMID 29797780 DOI: 10.1002/Ajim.22863 |
0.469 |
|
2018 |
Pfau JC. Immunotoxicity of asbestos Current Opinion in Toxicology. 10: 1-7. DOI: 10.1016/J.COTOX.2017.11.005 |
0.389 |
|
2017 |
Miller A, Szeinuk J, Noonan CW, Henschke CI, Pfau J, Black B, Yankelevitz DF, Liang M, Liu Y, Yip R, McNew T, Linker L, Flores R. Libby Amphibole Disease: Pulmonary Function and CT Abnormalities in Vermiculite Miners. Journal of Occupational and Environmental Medicine. PMID 29200190 DOI: 10.1097/Jom.0000000000001178 |
0.324 |
|
2017 |
Pfau JC, Buck B, Metcalf RV, Kaupish Z, Stair C, Rodriguez M, Keil DE. Comparative health effects in mice of Libby amphibole asbestos and a fibrous amphibole from Arizona. Toxicology and Applied Pharmacology. PMID 28870655 DOI: 10.1016/J.Taap.2017.08.022 |
0.461 |
|
2017 |
Gilmer J, Harding T, Woods L, Black B, Flores R, Pfau J. Mesothelial cell autoantibodies upregulate transcription factors associated with fibrosis. Inhalation Toxicology. 29: 10-17. PMID 28183202 DOI: 10.1080/08958378.2016.1271841 |
0.506 |
|
2017 |
Bernatsky SM, Pfau JC, Fritzler MJ. Environmental exposures and biomarkers predictive of rheumatoid arthritis and the pathway to precision medicine Journal of Laboratory and Precision Medicine. 2: 5-5. DOI: 10.21037/JLPM.2017.02.01 |
0.315 |
|
2016 |
Szeinuk J, Noonan CW, Henschke CI, Pfau J, Black B, Miller A, Yankelevitz DF, Liang M, Liu Y, Yip R, Linker L, McNew T, Flores RM. Pulmonary abnormalities as a result of exposure to Libby amphibole during childhood and adolescence-The pre-adult latency study (PALS). American Journal of Industrial Medicine. PMID 27859510 DOI: 10.1002/Ajim.22674 |
0.308 |
|
2016 |
Hanson R, Evilia C, Gilmer J, Woods L, Black B, Flores R, Pfau JC. Libby amphibole-induced mesothelial cell autoantibodies bind to surface plasminogen and alter collagen matrix remodeling. Physiological Reports. 4. PMID 27519611 DOI: 10.14814/phy2.12881 |
0.36 |
|
2016 |
Gilmer J, Serve K, Davis C, Anthony M, Hanson R, Harding T, Pfau JC. Libby Amphibole Induced Mesothelial Cell Autoantibodies Promote Collagen Deposition in Mice. American Journal of Physiology. Lung Cellular and Molecular Physiology. ajplung.00462.2015. PMID 27106292 DOI: 10.1152/Ajplung.00462.2015 |
0.696 |
|
2015 |
Carlin DJ, Larson TC, Pfau JC, Gavett SH, Shukla A, Miller A, Hines R. Current Research and Opportunities to Address Environmental Asbestos Exposures. Environmental Health Perspectives. 123: A194-7. PMID 26230287 DOI: 10.1289/Ehp.1409662 |
0.413 |
|
2015 |
Noonan CW, Conway K, Landguth EL, McNew T, Linker L, Pfau J, Black B, Szeinuk J, Flores R. Multiple pathway asbestos exposure assessment for a Superfund community. Journal of Exposure Science & Environmental Epidemiology. 25: 18-25. PMID 24756101 DOI: 10.1038/Jes.2014.25 |
0.488 |
|
2014 |
Pfau JC, Serve KM, Noonan CW. Autoimmunity and asbestos exposure. Autoimmune Diseases. 2014: 782045. PMID 24876951 DOI: 10.1155/2014/782045 |
0.727 |
|
2013 |
Serve KM, Black B, Szeinuk J, Pfau JC. Asbestos-associated mesothelial cell autoantibodies promote collagen deposition in vitro. Inhalation Toxicology. 25: 774-84. PMID 24304304 DOI: 10.3109/08958378.2013.848249 |
0.709 |
|
2012 |
Overocker J, Pfau JC. Cytokine Production Modified by System X(c)- After PM10 and Asbestos Exposure. Journal of Young Investigators. 23: 34-39. PMID 23418405 |
0.313 |
|
2012 |
Germolec D, Kono DH, Pfau JC, Pollard KM. Animal models used to examine the role of the environment in the development of autoimmune disease: findings from an NIEHS Expert Panel Workshop. Journal of Autoimmunity. 39: 285-93. PMID 22748431 DOI: 10.1016/j.jaut.2012.05.020 |
0.385 |
|
2012 |
Rasmussen DL, Pfau JC. Asbestos activates CH12.LX B-lymphocytes via macrophage signaling. Journal of Immunotoxicology. 9: 129-40. PMID 22133189 DOI: 10.3109/1547691X.2011.631953 |
0.366 |
|
2012 |
Marchand LS, St-Hilaire S, Putnam EA, Serve KM, Pfau JC. Mesothelial cell and anti-nuclear autoantibodies associated with pleural abnormalities in an asbestos exposed population of Libby MT. Toxicology Letters. 208: 168-73. PMID 22085844 DOI: 10.1016/J.Toxlet.2011.10.024 |
0.713 |
|
2011 |
Pfau JC, Li S, Holland S, Sentissi JJ. Alteration of fibroblast phenotype by asbestos-induced autoantibodies. Journal of Immunotoxicology. 8: 159-69. PMID 21457077 DOI: 10.3109/1547691X.2011.562257 |
0.521 |
|
2009 |
Cooper G, Gilbert K, Greidinger E, James J, Pfau J, Reinlib L, Richardson B, Rose N. Recent advances and opportunities in research on lupus: environmental influences and mechanisms of disease. CiêNcia & SaúDe Coletiva. 14: 1865-76. PMID 19851599 DOI: 10.1590/S1413-81232009000500028 |
0.438 |
|
2008 |
Pfau JC, Sentissi JJ, Li S, Calderon-Garciduenas L, Brown JM, Blake DJ. Asbestos-induced autoimmunity in C57BL/6 mice. Journal of Immunotoxicology. 5: 129-37. PMID 18569382 DOI: 10.1080/15476910802085756 |
0.475 |
|
2008 |
Blake DJ, Wetzel SA, Pfau JC. Autoantibodies from mice exposed to Libby amphibole asbestos bind SSA/Ro52-enriched apoptotic blebs of murine macrophages. Toxicology. 246: 172-9. PMID 18295955 DOI: 10.1016/J.Tox.2008.01.008 |
0.452 |
|
2007 |
Blake DJ, Bolin CM, Cox DP, Cardozo-Pelaez F, Pfau JC. Internalization of Libby amphibole asbestos and induction of oxidative stress in murine macrophages. Toxicological Sciences : An Official Journal of the Society of Toxicology. 99: 277-88. PMID 17578862 DOI: 10.1093/Toxsci/Kfm166 |
0.367 |
|
2006 |
Noonan CW, Pfau JC, Larson TC, Spence MR. Nested case-control study of autoimmune disease in an asbestos-exposed population. Environmental Health Perspectives. 114: 1243-7. PMID 16882533 DOI: 10.1289/ehp.9203 |
0.425 |
|
2005 |
Brown JM, Pfau JC, Pershouse MA, Holian A. Silica, apoptosis, and autoimmunity. Journal of Immunotoxicology. 1: 177-87. PMID 18958651 DOI: 10.1080/15476910490911922 |
0.452 |
|
2005 |
Brown JM, Schwanke CM, Pershouse MA, Pfau JC, Holian A. Effects of rottlerin on silica-exacerbated systemic autoimmune disease in New Zealand mixed mice. American Journal of Physiology. Lung Cellular and Molecular Physiology. 289: L990-8. PMID 16040631 DOI: 10.1152/ajplung.00078.2005 |
0.493 |
|
2005 |
Pfau JC, Sentissi JJ, Weller G, Putnam EA. Assessment of autoimmune responses associated with asbestos exposure in Libby, Montana, USA. Environmental Health Perspectives. 113: 25-30. PMID 15626643 |
0.495 |
|
2004 |
Brown JM, Pfau JC, Holian A. Immunoglobulin and lymphocyte responses following silica exposure in New Zealand mixed mice. Inhalation Toxicology. 16: 133-9. PMID 15204774 DOI: 10.1080/08958370490270936 |
0.393 |
|
2004 |
Pfau JC, Brown JM, Holian A. Silica-exposed mice generate autoantibodies to apoptotic cells. Toxicology. 195: 167-76. PMID 14751672 |
0.45 |
|
2003 |
Brown JM, Archer AJ, Pfau JC, Holian A. Silica accelerated systemic autoimmune disease in lupus-prone New Zealand mixed mice. Clinical and Experimental Immunology. 131: 415-21. PMID 12605693 DOI: 10.1046/j.1365-2249.2003.02094.x |
0.447 |
|
Show low-probability matches. |